Abstract:BACKGROUND: Anthropometric indices are used as predictors of cardiovascular disease (CVD). The most used indices are body mass index (BMI) and waist circumference (WC); however, there are limitations regarding their validity to address different body shapes, fat and lean mass distribution. A body shape index (ABSI) has been proposed as an alternative parameter to reflect differences in body shape and potentially be more useful for predicting CVD. ABSI is calculated by ABSI = WC / (BMI2/3 • Height1/2). The purpose of this cross-sectional study was to determine the utility of ABSI as a predictor or modifiable risk factor of CVD compared to other commonly used measures in clinical practice.METHODS: The sample population was from the baseline interview and health examination included in the National Health and Nutrition Examination Survey (NHANES) 2013-2014. Patients (n=5,924, 52% female) were aged 18-80 years (47.4 ± 18.4 years) who completed a series of questionnaires on a spectrum of health-related risks. After the interview, health technicians performed a standardized examination of the participants to collect data on weight, height, BMI, WC, and sagittal abdominal diameter (SAD). Statistical analysis was done using R Studio, version 0.99.903 (RStudio, Inc. Boston, MA). Using logistic regression, the correlation between each predictor (ABSI, BMI, WC, SAD) as a continuous variable, and CVD outcomes was evaluated with two models: a univariable model and a multivariable model. In a secondary analysis, ABSI was reclassified into categorical values based on quartiles of the NHANES dataset. Logistic regressions were again run for overall CVD and all CVD sub-categories, followed by chi-square tests for significance. For comparison, BMI categories of normal, overweight, obese, and severely obese were tested with overall CVD and all CVD subcategories as outcome measures, followed by chi-square tests for significance.RESULTS: Approximately 10% of the sample population had at least one prior manifestation of CVD, the most common being myocardial infarction (MI) (4.0%). ABSI showed little correlation with weight, BMI, WC, and SAD (r<0.3), while BMI had a strong correlation with weight, BMI, WC, and SAD (r ≈ 0.9). In univariable logistic regression, ABSI showed the most robust associations of all predictors with overall CVD and all CVD subcategories. ABSI demonstrated stronger correlations than BMI for all CVD outcomes (except CHF in the multivariable model). This study attempted to create classifications of ABSI and compare them to the normative classifications of BMI. In this categorical analysis, ABSI was also stronger than BMI in all logistic regression analyses for CVD outcomes, except for CHF in the multivariable model. Severe obesity (BMI ≥40 kg/m2) almost doubled the odds of having CVD, while being categorized in Q2, Q3, and Q4 for ABSI increased odds by double, triple, and eight-fold, respectively.CONCLUSION: An ABSI parameter in the upper three quartiles increases the risk of CVD manifestations more significantly than an elevated BMI per category of overweight, obese, and severely obese, respectively. Since the categories for ABSI were created based on quartiles of a large sample size reflecting the US population, this suggests that the increased risk from an elevated ABSI is more widespread than previously understood. Thus, ABSI should be monitored more closely and managed in preventative medical care than BMI alone.

Body shape index in comparison with other anthropometric measures in prediction of total and cause-specific mortality

A Body Shape Index (ABSI) achieves better mortality risk stratification than alternative indices of abdominal obesity: results from a large European cohort

The Abdominal Adiposity Index (A Body Shape Index) Predicts 10-Year All-Cause Mortality in Elderly Active Non-Obese Subjects

Anthropometric measures in cardiovascular disease prediction: comparison of laboratory-based versus non-laboratory-based model

Utility of a Body Shape Index Parameter in Predicting Cardiovascular Disease Risks

CVD-predictive performances of “a body shape index” versus simple anthropometric measures: Tehran lipid and glucose study

Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity

Low anthropometric measures and mortality—results from the Malmö Diet and Cancer Study

A body shape index is useful for BMI-independently identifying Japanese patients with obesity at high risk of cardiovascular disease

A Body Shape Index and Its Changes in Relation to All-Cause Mortality among the Chinese Elderly: A Retrospective Cohort Study

Risk of breast, endometrial, colorectal, and renal cancers in postmenopausal women in association with a body shape index and other anthropometric measures

Association of body indices with mortality in older population: Japan Specific Health Checkups (J‐SHC) Study

A Body Shape Index as a Simple Anthropometric Marker of Abdominal Obesity and Risk of Cardiovascular Events

A body shape index (ABSI) but not body mass index (BMI) is associated with prostate cancer‐specific mortality: Evidence from the US NHANES database

Surrogate Adiposity Markers and Mortality

Body Mass Index and Mortality: A 10-Year Prospective Study in China

Obesity measures, metabolic health and their association with 15-year all-cause and cardiovascular mortality in the SAMINOR 1 Survey: a population-based cohort study

Association of a body shape index with femur bone mineral density among older adults: NHANES 2007-2018

Body roundness index is a superior indicator to associate with the cardio‐metabolic risk: evidence from a cross‐sectional study with 17,000 Eastern-China adults

Differences between adiposity indicators for predicting all-cause mortality in a representative sample of United States non-elderly adults

Association of Waist Circumference and Body Mass Index Deciles Ratio with All-Cause Mortality: Findings from the National Health and Nutrition Examination Survey